Systems Biology and Animal Models: STRIDE

Size: px
Start display at page:

Download "Systems Biology and Animal Models: STRIDE"

Transcription

1 Systems Biology and Animal Models: STRIDE Michael G Katze, Ph.D. presentation to Eighth Comparative Medicine Resource Directors Meeting May 10th, 2010

2 Questions What Pandemics Are We Currently Experiencing? A) HIV/AIDS B) Hepatitis C C) Swine Flu (H1N1) D) All of the above

3 Answer: D - All of the above

4 TRUE or FALSE? We do NOT have an AIDS Vaccine?

5 TRUE OR FALSE? Something Has To Change

6 KEY POINTS-DEFINITIONS TO REMEMBER What Is Systems Biology? What Is STRIDE? Prototype for Enabling Researchers Growth in Primate Genomics New Directions through Collaboration Information Overload POST GENOMICS AGE Paradigm Shift-New Vocabulary

7 Denis Noble: The Music of Life: Biology beyond the Genome Systems biology...is about putting together rather than taking apart, integration rather than reduction. It requires that we develop ways of thinking about integration that are as rigorous as our reductionist programmes, but different...it means changing our philosophy, in the full sense of the term Oxford University Press, (8 Jun 2006)

8 Systems Biology Paradigm

9 Current NHP SYSTEMS BIOLOGY Research Efforts NHP Models of Respiratory Disease 2009 Swine-origin H1N1 Influenza A Expression Analysis by Arrays Proteomics Analysis Agilent Collaboration NextGen Sequencing ABI Collaboration 1918 Pandemic Influenza vs. Highly Pathogenic Avian Influenza (HPAI) HPAI vs. reassortants of 1918 Pandemic Influenza (Battelle Infection Model) Filovirus Studies Correlates of protection in Ebola vaccine studies AIDS Pathogenesis and Vaccine Related Studies Natural Infections in AGM SVEU Vaccine Study Differences among DNA Vaccine Regimens NIDA P01 Proteomics Center opiate impact on pathogenesis in natural host HVTN STEP Profiling Vaccinees vs. Placebo, with impact of Ad5 Immunity In vitro HIV/SIV Systems Biology in controlled experimental context

10 How Can We Best Apply Systems Biology Approaches To Achieve Our Goal Of Improving Human Health?

11 Experience We Have Had Success Putting Together And Participating In Large Multidisciplinary Programs. Pacific Northwest Regional Center of Excellence NIDA Center for Functional Genomics Systems Biology Contract This experience and infrastructure can be leveraged by STRIDE

12 STRIDE- E IS FOR ENABLE STRIDE Represents A Prototype Center For Simultaneously Performing Basic Research And Enabling Collaboration Between A Diverse Group Of Scientists As Well As Giving Them Access To A Systems Biology Toolkit. Stimulus money Multi-center helping effort to fund that STRIDE continues through to grow Training Grants

13 Participating Institutions

14 Focus on Translational Research Taken from the ITHS website T0 is characterized by the identification of opportunities and approaches to health problems. T1 seeks to move basic discovery into a candidate health application. T2 assesses the value of application for health practice leading to the development of evidence-based guidelines. T3 attempts to move evidencebased guidelines into health practice, through delivery, dissemination, and diffusion research. T4 seeks to evaluate the real world health outcomes of population health practice.

15 New Community Context and Associations NCRR Informatics Initiative to integrate data and information on animal models Enable community to locate, identify, apply most useful animal models Anticipating WaNPRC and our Division as contributors to this effort Extensive knowledge of NHP models of viral diseases Extensive informatics infrastructure Advisory role in planning and resource prioritization Contributing role as generating models and linking to our genomics and other high-throughput data sets.

16

17 Collaborative Cross Mice Wide Range of Outcomes Percent Starting Mass 110 loss Weight Loss Virus challenge Days post challenge >400 genetically distinct strains

18 Acknowledgements - UNC Martin Ferris, Ralph Baric, Matt Frieman, Mark Heise, Fernando Pardo-Manuel de Villena

19

20

21 STRIDE RESOURCES

22 Current Collaborative Systems Biology Research Projects

23 New Collaborative Research Projects 1. Genomic profiling of pathogen-host interactions of oncogenic gammaherpesviruses in vivo. Timothy M. Rose, Ph.D. 2. Alterations of cellular metabolism by oncogenic herpesvirus. Michael Lagunoff, Ph.D. 3. BioGRID curation effort to systematically capture literature interactions and post-translational modifications for every human protein known to be either associated with or influenced by HIV-encoded factors. Mike Tyers, Ph.D. and Kara Dolinski, Ph.D. (Princeton University) Affiliated with LAMHDI

24 STRIDE Funding RC4 Recently Submitted

25 Leveraging STRIDE To Enhance Non- Human Primate Genomics Research

26 Growth in Primate Genomics Primate (2 (3 (4 nd rd th ) Seattle Genomics The Macaque International Workshop, Genome Conference January 2001 on on Primate Primate Genomics, Genomics, March April Consortium Publishes Attended In 2005, NHGRI by 90 participants initiates the that $20 included million dollar the Directors rhesus macaque of the eight National sequencing Attended Primate by project approximately Research Centers, 130 scientists Macaque NIH staff, from and Genome academia investigators and Attended by by more approximately than 190 scientists 170 scientists from diverse research working industry. on Members genomics of and the evolutionary nonhuman primate biology, models primate of research, backgrounds Introduction of a Bioinformatics This Workshop enables to refinement expose nonhuman and disease. genome sciences, AIDS, and infectious disease and biodefense primate Interest researchers in Bioinformatics to high-throughput Workshop improved so accuracy research much that tools of we macaquespecific and had making to cap communities This meeting, were the represented, first ever of its as kind, were was the productive NCRR Division and of registration sense of the data successful Comparative on Medicine multiple levels. and the First Office and of resources foremost, AIDS Research. as well as Caliber of Keynote speakers and attendees highlight it provided the success the of impetus Provided to NCRR a platform and NIH for roll-out critical to expand of newly data funding generated for comparative for research nonhuman previous conferences and increased interest in Primate Genomics in primate genomics. primate research tools including evolutionary macaque-specific genomics oligonucleotide microarrays.

27 Current Nonhuman Primate Genomics Efforts - STRIDE Reference RNA SEQ Transcriptome Project Born out of the 4 th International Primate Genomics Conference Collaboration between Industry (ILLUMINA-ABI (?)) and Academic Institutions Leveraging Next Generation Sequencing Technology Multiple tissues from ~12-18 nonhuman primate species of medical and evolutionary importance Data will be accessible by entire research community Genome 10K Project Steve O Brien et al (NCI) The Genome 10K project aims to assemble a genomic zoo a collection of DNA sequences representing the genomes of 10,000 vertebrate species How can we best leverage and intersect these two efforts? With help from STRIDE as a coordinating model, we will establish an international consortium on nonhuman primate genome sequencing

28 The World of Non- Human Primate Research Has Changed Forever

29 MOREOVER RUMOR HAS IT.. NHGRI Has Committed to Sequencing 30 Non- Human Primate Genomes?

30

31 IF NOT NIH THEN.?????

32 ALL OF THESE EFFORTS WILL BE GENERATING AN ENORMOUS AMOUNT OF DATA

33 Information Overload? New York Times April 2009

34 High-throughput Technologies are Generating an Unprecedented Amount of DATA How will researchers not currently involved with these technologies access and leverage this DATA? How will we ensure limited amounts of redundancy when generating genomic resources? How can we more quickly translate this DATA in to medical achievements? Role for BIRN? WITH TECHNOLOGY MOVING SO FAST, WE HAVE TO EVOLVE OUR PROCESS AND WAYS OF THINKING TO ACCOMMODATE AND TRANSLATE THE INFORMATION IN TO BETTER HUMAN HEALTH

35 The STRIDE Centers Goal Is To Enable Those Connections And Provide Access To The Appropriate Tools To achieve a truly systems level view utilizing highthroughput technologies, researchers from diverse backgrounds need to be connected and tools have to be put in place for effective interpretation and communication

36 Katze Lab Computational Biology Data Capture Data Access Statistical & Functional Analysis Integrative Analysis & Modeling Robust IT Infrastructure Scalable Computing Infrastructure LabKey Development Web Portal Development Enterprise Application Deployment Resolver / GeneData / GeneSpring Ingenuity IPA GeneGo MetaCore Spotfire DecisionSite Advanced Method Development NextGen Capability Host Response Compendium Multi-Omic Integrative Analysis Network Analysis

37 Robust IT Infrastructures Software Hardware

38 KEY POINTS-DEFINITIONS TO REMEMBER What Is Systems Biology? What Is STRIDE? Prototype for Enabling Researchers Growth in Primate Genomics New Directions through Collaboration Information Overload POST GENOMICS AGE Paradigm Shift-New Vocabulary

39 STRIDE-Solving The Puzzle Through Systems Biology Michael Katze

Synthetic Genomics and Its Application to Viral Infectious Diseases. Timothy Stockwell (JCVI) David Wentworth (JCVI)

Synthetic Genomics and Its Application to Viral Infectious Diseases. Timothy Stockwell (JCVI) David Wentworth (JCVI) Synthetic Genomics and Its Application to Viral Infectious Diseases Timothy Stockwell (JCVI) David Wentworth (JCVI) Outline Using informatics to predict drift (strain selection) Synthetic Genomics: Preparedness

More information

Product Development for Public Health & Emerging Infections

Product Development for Public Health & Emerging Infections Product Development for Public Health & Emerging Infections Michael G Kurilla, MD-PhD Director, Office of BioDefense Research Affairs Division of Microbiology & Infectious Diseases Associate Director,

More information

APHL Next Generation Sequencing (NGS) Survey

APHL Next Generation Sequencing (NGS) Survey Next Generation Sequencing 1. How long has your lab had a sequencer? [If lab does not have a sequencer go to 1a1 through 1a3 and then end survey] [If lab does have a sequencer continue to 1a and the rest

More information

UNRAVELING THE MYSTERY BEHIND HIV/AIDS

UNRAVELING THE MYSTERY BEHIND HIV/AIDS PRESS RELEASE 3 MAR 2010 UNRAVELING THE MYSTERY BEHIND HIV/AIDS New findings by Nobel Laureate shed light on the elusive AIDS virus and may lead to effective HIV vaccine development 1. Professor Francoise

More information

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary The President s FY 2009 Budget Request for the Centers for Disease Control and Prevention (CDC) discretionary funding is

More information

PIP Framework Information Session 10 April 2018

PIP Framework Information Session 10 April 2018 Pandemic Influenza Preparedness Framework Sharing of influenza viruses & access to vaccines and other benefits PIP Framework Information Session 10 April 2018 PIP Framework Information Session Purpose:

More information

Planning, Priority Setting, and Budget Development for NIH AIDS Research

Planning, Priority Setting, and Budget Development for NIH AIDS Research Planning, Priority Setting, and Budget Development for NIH AIDS Research Robert W. Eisinger, Ph.D. Office of AIDS Research s of Health Focus of Presentation Overview of OAR Priority Setting Process Budget

More information

Evolution of influenza

Evolution of influenza Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal

More information

National Vaccine Plan Goal 4 Immunization Information Systems. Mike Garcia Scientific Technologies Corporation 24 July 2008

National Vaccine Plan Goal 4 Immunization Information Systems. Mike Garcia Scientific Technologies Corporation 24 July 2008 National Vaccine Plan Goal 4 Immunization Information Systems Mike Garcia Scientific Technologies Corporation 24 July 2008 Immunization Information Systems (IIS) role in the Goal: Achieve better use of

More information

Health Task Force Workplan

Health Task Force Workplan 2006/SOM 3/HTF/021 Agenda Item: VI Health Task Force Workplan 2006-2007 Purpose: Information Submitted by: Chair Health Task Force Meeting Da Nang, Viet Nam 14 15 September 2006 APEC HEALTH TASK FORCE

More information

HIV/AIDS Research Portfolio Review Working Groups Submits Science Priorities Report to NIH Director

HIV/AIDS Research Portfolio Review Working Groups Submits Science Priorities Report to NIH Director HIV/AIDS Research Portfolio Review Working Groups Submits Science Priorities Report to NIH Director June 16, 2014 On May 28, the National Institutes of Health (NIH) HIV/AIDS Research Portfolio Review Working

More information

NIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH

NIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH NIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH AAMC Webinar November 8, 2018 Walter J. Koroshetz, MD Director, National Institute of Neurological

More information

Vaccines: Reaching for higher branches after the low hanging fruit has been picked

Vaccines: Reaching for higher branches after the low hanging fruit has been picked Engineering Conferences International ECI Digital Archives Vaccine Technology VI Proceedings 6-12-2016 Vaccines: Reaching for higher branches after the low hanging fruit has been picked Michael G. Kurilla

More information

Nanoparticulate Vaccine Design: The VesiVax System

Nanoparticulate Vaccine Design: The VesiVax System Nanoparticulate Vaccine Design: The VesiVax System Gary Fujii, Ph.D. President and CEO Molecular Express, Inc. May 16, 2006 Orlando, Florida Influenza Each year up to 20% of the world's population contracts

More information

Page 1 of 5 For Immediate Release Office of the Press Secretary July 17, 2007 Fact Sheet: Implementation of the National Strategy for Pandemic Influenza A One-Year Summary Of Efforts To Better Protect

More information

RITM Laboratory Response During the 2009 Influenza H1N1 Pandemic

RITM Laboratory Response During the 2009 Influenza H1N1 Pandemic RITM Laboratory Response During the 2009 Influenza H1N1 Pandemic REMIGIO M. OLVEDA, MD Director IV Research Institute for Tropical Medicine-DOH Philippines RITM Pre-Pandemic Preparedness Plan Ongoing surveillance

More information

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS 8-9 December 2015 Executive summary On 8-9 December,

More information

Global Pandemic Preparedness Research Efforts. Klaus Stöhr. WHO Global Influenza Programme. Today

Global Pandemic Preparedness Research Efforts. Klaus Stöhr. WHO Global Influenza Programme. Today Global Pandemic Preparedness Research Efforts Klaus Stöhr 3 Today Medium-term applied research linked to medical and public health interventions addressing the current pandemic situation in Asia Natural

More information

LESSON 4.5 WORKBOOK. How do viruses adapt Antigenic shift and drift and the flu pandemic

LESSON 4.5 WORKBOOK. How do viruses adapt Antigenic shift and drift and the flu pandemic DEFINITIONS OF TERMS Gene a particular sequence of DNA or RNA that contains information for the synthesis of a protien or RNA molecule. For a complete list of defined terms, see the Glossary. LESSON 4.5

More information

A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES

A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES Since 1888, date of its creation, has been committed to contain infectious diseases by working directly in regions where

More information

2.1 VIRUSES. 2.1 Learning Goals

2.1 VIRUSES. 2.1 Learning Goals 2.1 VIRUSES 2.1 Learning Goals To understand the structure, function, and how Viruses replicate To understand the difference between Viruses to Prokaryotes and Eukaryotes; namely that viruses are not classified

More information

Vaccines and Immunization research & development

Vaccines and Immunization research & development 32 nd International conference on Vaccines and Immunization research & development 0 http://vaccines.global-summit.com/america/ Invitation Dear Attendees, We are glad to announce the 32 nd International

More information

OFFLU the joint OIE-FAO network of expertise on animal influenza

OFFLU the joint OIE-FAO network of expertise on animal influenza OFFLU the joint OIE-FAO network of expertise on animal influenza FAO/OIE HPAI Laboratory Network Meeting for SE Asia Keith Hamilton OIE Scientific and Technical Department, OIE Paris OFFLU Objectives Share

More information

Bjoern Peters La Jolla Institute for Allergy and Immunology Buenos Aires, Oct 31, 2012

Bjoern Peters La Jolla Institute for Allergy and Immunology Buenos Aires, Oct 31, 2012 www.iedb.org Bjoern Peters bpeters@liai.org La Jolla Institute for Allergy and Immunology Buenos Aires, Oct 31, 2012 Overview 1. Introduction to the IEDB 2. Application: 2009 Swine-origin influenza virus

More information

Proliferation Threats from Biotechnology: What is Dual-Use Research?

Proliferation Threats from Biotechnology: What is Dual-Use Research? Proliferation Threats from Biotechnology: What is Dual-Use Research? In Class Discussion Break into groups of 3, come up with definition dual use and present to class Biological Dual-Use Research Biotechnology

More information

Opportunities in Pain Research with the NIH HEAL Initiative

Opportunities in Pain Research with the NIH HEAL Initiative Opportunities in Pain Research with the NIH HEAL Initiative Clinton Wright, M.D. Director, Division of Clinical Research National Institute of Neurological Disorders and Stroke, NIH September 20, 2018

More information

the Office of Research Application Portal: Materials to submit:

the Office of Research Application Portal:   Materials to submit: Title: PAR 17 237: Centers for AIDS Research (P30) Slots: 1 Internal Deadline: LOI: External Deadline: Award Information: Submission Process: May 26, 2018, 5pm PDT 30 days prior to the application due

More information

Center for Biologics Evaluation and Research

Center for Biologics Evaluation and Research Center for Biologics Evaluation and Research Current Activities Future Directions Washington, DC January 25, 2010 Karen Midthun, MD Acting Director, CBER CBER Our Mission To ensure the safety, purity,

More information

PROMOTING AN EFFECTIVE MEDICAL COUNTERMEASURES ENTERPRISE

PROMOTING AN EFFECTIVE MEDICAL COUNTERMEASURES ENTERPRISE PROMOTING AN EFFECTIVE MEDICAL COUNTERMEASURES ENTERPRISE Gerald R. Kovacs, PhD Director, Division of Chem/Bio/Rad/Nuc Medical Countermeasures Biomedical Advanced Research and Development Authority Assistant

More information

University of Pittsburgh Cancer Institute UPMC CancerCenter. Uma Chandran, MSIS, PhD /21/13

University of Pittsburgh Cancer Institute UPMC CancerCenter. Uma Chandran, MSIS, PhD /21/13 University of Pittsburgh Cancer Institute UPMC CancerCenter Uma Chandran, MSIS, PhD chandran@pitt.edu 412-648-9326 2/21/13 University of Pittsburgh Cancer Institute Founded in 1985 Director Nancy Davidson,

More information

Following virus recombination and evolution

Following virus recombination and evolution Following virus recombination and evolution Coping with the avalanche of sequencing data Dmitry Kusnetsov, Anne Gleizes, Robin Liechti, Ioannis Xenarios, Philippe Le Mercier Vital-IT/Swiss-Prot group SIB

More information

Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems:

Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems: Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems: National capabilities in public health systems Indonesia

More information

PRECISION INSIGHTS. GPS Cancer. Molecular Insights You Can Rely On. Tumor-normal sequencing of DNA + RNA expression.

PRECISION INSIGHTS. GPS Cancer. Molecular Insights You Can Rely On. Tumor-normal sequencing of DNA + RNA expression. PRECISION INSIGHTS GPS Cancer Molecular Insights You Can Rely On Tumor-normal sequencing of DNA + RNA expression www.nanthealth.com Cancer Care is Evolving Oncologists use all the information available

More information

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS APRIL 2017 Infectious viruses are a global health threat Since the approval of the first antiviral drug

More information

U.S. Readiness for Pandemics

U.S. Readiness for Pandemics 0 U.S. Readiness for Pandemics 5 th National Emergency Management Summit Brooklyn, NY September 15, 2011 Robin Robinson, Ph.D. Deputy Assistant Secretary for Preparedness & Response (HHS/ASPR) Director

More information

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS MAY 2017 1 Infectious viral pathogens are a significant global health threat to mankind 2 Since the approval

More information

Experimental Design for Immunologists

Experimental Design for Immunologists Experimental Design for Immunologists Hulin Wu, Ph.D., Dean s Professor Department of Biostatistics & Computational Biology Co-Director: Center for Biodefense Immune Modeling School of Medicine and Dentistry

More information

Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS

Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS 1 Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS What steps are involved in viral infection and replication? Why are some kinds of influenza virus more deadly than others? How do flu

More information

TRANS-NIH PLAN FOR HIV RELATED RESEARCH

TRANS-NIH PLAN FOR HIV RELATED RESEARCH National Institutes of Health FY 2018 TRANS-NIH PLAN FOR HIV RELATED RESEARCH Prepared by the Office of AIDS Research Maureen M. Goodenow, Ph.D. NIH Associate Director for AIDS Research and Director, Office

More information

Pandemic Influenza Preparedness and Response

Pandemic Influenza Preparedness and Response 24 th Meeting of Ministers of Health Dhaka, Bangladesh, 20-21 August 2006 SEA/HMM/Meet.24/4(b) 10 July 2006 Pandemic Influenza Preparedness and Response Regional situation: Human cases and outbreaks of

More information

HVTN 505 Study HIV Vaccine Candidate Not Effective

HVTN 505 Study HIV Vaccine Candidate Not Effective Subscribe Unsubscribe HVTN 505 Study HIV Vaccine Candidate Not Effective The National Institute of Allergy and Infectious Diseases (NIAID) and the HIV Vaccine Trials Network have announced there will be

More information

Association of American Cancer Institutes

Association of American Cancer Institutes Association of American Cancer Institutes Statement by the Association of American Cancer Institutes on Fiscal Year (FY) 2016 Appropriations for the Department of Health and Human Services Subcommittee

More information

EU REFERENCE LABORATORIES FOR AVIAN INFLUENZA AND NEWCASTLE DISEASE

EU REFERENCE LABORATORIES FOR AVIAN INFLUENZA AND NEWCASTLE DISEASE EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL G2- Animal Health 04 Veterinary Control programmes SANCO/7048/204 Draft Working document EU REFERENCE LABORATORIES FOR AVIAN INFLUENZA AND NEWCASTLE

More information

Overview: Chapter 19 Viruses: A Borrowed Life

Overview: Chapter 19 Viruses: A Borrowed Life Overview: Chapter 19 Viruses: A Borrowed Life Viruses called bacteriophages can infect and set in motion a genetic takeover of bacteria, such as Escherichia coli Viruses lead a kind of borrowed life between

More information

Development of an Influenza Risk Assessment Tool

Development of an Influenza Risk Assessment Tool Development of an Influenza Risk Assessment Tool Susan C. Trock, DVM, MPH, Dip. ACVPM (Epi) Influenza Division, NCIRD, CDC OFFLU Technical Meeting, April 5, 2012 National Center for Immunization & Respiratory

More information

Pandemic Influenza Preparedness Framework. Sharing influenza viruses & access to vaccines and other benefits

Pandemic Influenza Preparedness Framework. Sharing influenza viruses & access to vaccines and other benefits Pandemic Influenza Preparedness Framework Sharing influenza viruses & access to vaccines and other benefits What is PIP? Landmark, innovative public health arrangement to increase global preparedness to

More information

New Opportunities in Cancer Research National Academy of Sciences Advancing Health Research in Poland and the United States December 3, 2009

New Opportunities in Cancer Research National Academy of Sciences Advancing Health Research in Poland and the United States December 3, 2009 New Opportunities in Cancer Research National Academy of Sciences Advancing Health Research in Poland and the United States December 3, 2009 Anna D. Barker, Ph.D. Deputy Director, NCI Cancer is a Current

More information

Tool for Pandemic Influenza Risk Assessment (TIPRA) Presented by Gina Samaan Global Influenza Programme

Tool for Pandemic Influenza Risk Assessment (TIPRA) Presented by Gina Samaan Global Influenza Programme Tool for Pandemic Influenza Risk Assessment (TIPRA) Presented by Gina Samaan Global Influenza Programme Context Rapid Risk Assessment of Acute Public Health Events (WHO, 2012) Need for specific risk assessment

More information

Lecture 19 Evolution and human health

Lecture 19 Evolution and human health Lecture 19 Evolution and human health The evolution of flu viruses The evolution of flu viruses Google Flu Trends data US data Check out: http://www.google.org/flutrends/ The evolution of flu viruses the

More information

Patricia Fitzgerald-Bocarsly

Patricia Fitzgerald-Bocarsly FLU Patricia Fitzgerald-Bocarsly October 23, 2008 Orthomyxoviruses Orthomyxo virus (ortho = true or correct ) Negative-sense RNA virus (complementary to mrna) Five different genera Influenza A, B, C Thogotovirus

More information

NIAID Oversight of Clinical Research and Funding Opportunities

NIAID Oversight of Clinical Research and Funding Opportunities NIAID Oversight of Clinical Research and Funding Opportunities The Fundamentals of International Clinical Research Workshop Dar es Salaam, Tanzania Polly R. Sager, Ph.D. Division of Microbiology and Infectious

More information

100 Years since the 1918 Spanish Flu Pandemic. Current Standards for Flu Pandemic Preparedness

100 Years since the 1918 Spanish Flu Pandemic. Current Standards for Flu Pandemic Preparedness 100 Years since the 1918 Spanish Flu Pandemic. Current Standards for Flu Pandemic Preparedness OCTOBER 16, 2018 SALLY A. HOJVAT M.Sc., Ph.D. Retired as Director of FDA Division of Microbiology Devices,

More information

A Bioinformatics Method for Identifying RNA Structures within Human Cells

A Bioinformatics Method for Identifying RNA Structures within Human Cells Wright State University CORE Scholar Physics Seminars Physics 11-1-2013 A Bioinformatics Method for Identifying RNA Structures within Human Cells Stephen Donald Huff Follow this and additional works at:

More information

INFLUENZA PANDEMIC CONTINUED FOCUS ON THE NATION S PLANNING AND PREPAREDNESS EFFORTS REMAINS ESSENTIAL

INFLUENZA PANDEMIC CONTINUED FOCUS ON THE NATION S PLANNING AND PREPAREDNESS EFFORTS REMAINS ESSENTIAL INFLUENZA PANDEMIC CONTINUED FOCUS ON THE NATION S PLANNING AND PREPAREDNESS EFFORTS REMAINS ESSENTIAL page 1 / 5 page 2 / 5 influenza pandemic continued focus pdf The 2009 flu pandemic or swine flu was

More information

PREventing EMerging Pathogenic Threats (PREEMPT) Proposers Day

PREventing EMerging Pathogenic Threats (PREEMPT) Proposers Day PREventing EMerging Pathogenic Threats (PREEMPT) Proposers Day Dr. Jim Gimlett, Program Manager DARPA Biological Technologies Office (BTO) January 30, 2018 Arlington, VA PREEMPT Agenda Proposers Day Objectives

More information

SEA/CD/154 Distribution : General. Avian Influenza in South-East Asia Region: Priority Areas for Research

SEA/CD/154 Distribution : General. Avian Influenza in South-East Asia Region: Priority Areas for Research SEA/CD/154 Distribution : General Avian Influenza in South-East Asia Region: Priority Areas for Research World Health Organization Publications of the World Health Organization enjoy copyright protection

More information

2014 Towards an HIV Cure symposium Melbourne The Role of a Public-Private Partnership in HIV Cure

2014 Towards an HIV Cure symposium Melbourne The Role of a Public-Private Partnership in HIV Cure 2014 Towards an HIV Cure symposium Melbourne The Role of a Public-Private Partnership in HIV Cure Mike McCune, MD, PhD University of California, San Francisco Cure Interventions that Can Be Used Around

More information

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication DEFINITIONS OF TERMS Eukaryotic: Non-bacterial cell type (bacteria are prokaryotes).. LESSON 4.4 WORKBOOK How viruses make us sick: Viral Replication This lesson extends the principles we learned in Unit

More information

genomics for systems biology / ISB2020 RNA sequencing (RNA-seq)

genomics for systems biology / ISB2020 RNA sequencing (RNA-seq) RNA sequencing (RNA-seq) Module Outline MO 13-Mar-2017 RNA sequencing: Introduction 1 WE 15-Mar-2017 RNA sequencing: Introduction 2 MO 20-Mar-2017 Paper: PMID 25954002: Human genomics. The human transcriptome

More information

Submitted electronically to:

Submitted electronically to: Submitted electronically to: ODOARRFI19@nih.gov Maureen Goodenow, PhD Associate Director of AIDS Research, NIH Director, Office of AIDS Research (OAR) National Institutes of Health 5601 Fishers Lane. Room

More information

Planning for Pandemic Influenza

Planning for Pandemic Influenza Planning for Pandemic Influenza John Kobayashi Faculty, Northwest Center for Public Health Practice, Foreign Advisor with the Field Epidemiology Training Program in Japan Pandemic Influenza as a Paradigm

More information

Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays

Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays About the author Disclaimer EXECUTIVE SUMMARY Molecular diagnostic technologies Healthcare-associated infections Sexually transmitted HPVs HIV and hepatitis viruses Market outlook and forecasts Molecular

More information

Influenza; tracking an emerging pathogen by popularity of Google Searches

Influenza; tracking an emerging pathogen by popularity of Google Searches Davids 1 Influenza; tracking an emerging pathogen by popularity of Google Searches Background Influenza is a wide spread and occasionally fatal disease, typically infecting children and the elderly. Each

More information

Summary of Data Dissemination Working Group. 22Jan2016

Summary of Data Dissemination Working Group. 22Jan2016 Summary of Data Dissemination Working Group 22Jan2016 Overview Review of Data Dissemination Working Group Strategy for data dissemination Testing of model and submission process Systems Biology Centers

More information

Developing the next generation of infection and immunity leaders. The Peter Doherty Institute for Infection and Immunity

Developing the next generation of infection and immunity leaders. The Peter Doherty Institute for Infection and Immunity Developing the next generation of infection and immunity leaders The Peter Doherty Institute for Infection and Immunity Nobody can decide to discover something, but there are ways of making a discovery

More information

Letter from the CEO. Dear Friends of IAVI,

Letter from the CEO. Dear Friends of IAVI, IAVI Annual Report 2017 Letter from the CEO Dear Friends of IAVI, We are pleased to present an overview of the progress IAVI and partners have made in 2017 toward our pursuit of the development of vaccines

More information

Government Bioscience Grant (GBG) Report April 2015

Government Bioscience Grant (GBG) Report April 2015 www.g2gconsulting.com www.michbio.org Government Bioscience Grant (GBG) Report April 2015 Title (Agency) Opp. Number Description Deadlin e Funding Level Eligibility Link KIDNEY 1 Pilot and Feasibility

More information

Public Health Preparedness and Response Update

Public Health Preparedness and Response Update Public Health Preparedness and Response Update August 3 rd, 2010 San Francisco Department of Public Health Office of Policy and Planning Preparedness Vision Vision The San Francisco Department of Public

More information

Cloudbreak. January Cidara Therapeutics

Cloudbreak. January Cidara Therapeutics Cloudbreak January 2019 Cidara Therapeutics 2019 0 Forward-Looking Statements These slides and the accompanying oral presentation contain forward-looking statements within the meaning of the Private Securities

More information

EVOLUTION: WHY DOES IT MATTER? What did evolution ever do for me?

EVOLUTION: WHY DOES IT MATTER? What did evolution ever do for me? EVOLUTION: WHY DOES IT MATTER? What did evolution ever do for me? www.christs.cam.ac.uk/darwin200 Evolution is change in living things through descent with modification Evolution is change in living things

More information

Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience

Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience Head of Delegation HERAWATI SUDOYO MD, PHD Eijkman Institute for Molecular Biology Ministry for Research and Technology

More information

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON VIRUSES Biology Applications Control David R. Harper GS Garland Science Taylor & Francis Group NEW YORK AND LONDON vii Chapter 1 Virus Structure and 2.2 VIRUS MORPHOLOGY 26 Infection 1 2.3 VIRAL CLASSIFICATION

More information

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? 8 th International Conference GLOBAL HEALTH CONSORTIUM Building Alliances in Global Health Miami, May 22-25, 2018 EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? José Esparza MD, PhD - Adjunct

More information

Fogarty Initiatives for Building Capacity in HIV/AIDS

Fogarty Initiatives for Building Capacity in HIV/AIDS Fogarty Initiatives for Building Capacity in HIV/AIDS April 13, 2010 Michael P. Johnson, M.D., M.P.H Deputy Director Fogarty International Center Global Health Transition in 21 st Century the unfinished

More information

1:15 2:00 KEYNOTE ADDRESS:

1:15 2:00 KEYNOTE ADDRESS: GHDx Course 1 Point-of-Care Diagnostics for Global Health July 13 July 17, 2009 University of Washington, Seattle, WA http://www.path.org/dxcenter/ Day 1 Monday (July 13 th, 2009) 8:30 8:45 Outline of

More information

Getting the Most Out of Baculovirus. Linda Lua

Getting the Most Out of Baculovirus. Linda Lua Getting the Most Out of Baculovirus Linda Lua Enabling World Class Research Recombinant Protein Production Discovery, Translational, Preclinical Drug discovery, vaccinology, diagnostics, functional materials,

More information

Increasing Adult Immunization Rates in the US Through Data and Quality: A Roadmap

Increasing Adult Immunization Rates in the US Through Data and Quality: A Roadmap Increasing Adult Immunization Rates in the US Through Data and Quality: A Roadmap Avalere Health An Inovalon Company November 16, 2017 In Partnership with GSK Agenda 1 2 3 4 5 Welcome & Introductions Overview:

More information

EC research and innovation strategy and actions

EC research and innovation strategy and actions EC research and innovation strategy and actions for preparedness and response to outbreaks IMI Stakeholder Forum 28-29 September 2016 Line Matthiessen Head of Unit E.3 Health Directorate DG Research &

More information

INFLUENZA-2 Avian Influenza

INFLUENZA-2 Avian Influenza INFLUENZA-2 Avian Influenza VL 7 Dec. 9 th 2013 Mohammed El-Khateeb Overview 1. Background Information 2. Origin/History 3. Brief overview of genome structure 4. Geographical Distribution 5. Pandemic Nature

More information

HS-LS4-4 Construct an explanation based on evidence for how natural selection leads to adaptation of populations.

HS-LS4-4 Construct an explanation based on evidence for how natural selection leads to adaptation of populations. Unit 2, Lesson 2: Teacher s Edition 1 Unit 2: Lesson 2 Influenza and HIV Lesson Questions: o What steps are involved in viral infection and replication? o Why are some kinds of influenza virus more deadly

More information

2009 / 2010 H1N1 FAQs

2009 / 2010 H1N1 FAQs The information contained within this document was compiled from sources that include the Center for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, and the Oregon Department

More information

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home Center for Global Health CDC Global Health Saving Lives Overseas, Protecting Americans at Home CDC Overview Part of the U.S. Department of Health and Human Services, CDC is the nation s leading public

More information

Viruses. Rotavirus (causes stomach flu) HIV virus

Viruses. Rotavirus (causes stomach flu) HIV virus Viruses Rotavirus (causes stomach flu) HIV virus What is a virus? A virus is a microscopic, infectious agent that may infect any type of living cell. Viruses must infect living cells in order to make more

More information

Lecture 2 Evolution in action: the HIV virus

Lecture 2 Evolution in action: the HIV virus Lecture 2 Evolution in action: the HIV virus Peter and Rosemary Grant Barry Sinervo The HIV/AIDS pandemic Life expectancy in Botswana What is HIV? What is HIV? HIV is a retrovirus (i.e., RNA-based) with

More information

Approaches to Pandemic Influenza Vaccine Preparedness

Approaches to Pandemic Influenza Vaccine Preparedness United States Department of Health & Human Services Office of the Assistant Secretary for Preparedness and Response Approaches to Pandemic Influenza Vaccine Preparedness Julie Schafer, MPH, MS Influenza

More information

Meeting Minutes. Date: Wednesday, October 18, 2017 Time: 10:00 AM 12:00 PM

Meeting Minutes. Date: Wednesday, October 18, 2017 Time: 10:00 AM 12:00 PM Meeting Minutes Date: Wednesday, October 18, 2017 Time: 10:00 AM 12:00 PM Location: Members Present: Foege N-130A 1. Garry Hamilton (Community Member) 2. Kevin Hybiske, Allergy and Infectious Diseases

More information

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges? Current Vaccines: Progress & Challenges Influenza Vaccine what are the challenges? Professor John S. Tam The Hong Kong Polytechnic University Asia-Pacific Alliance for the Control of Influenza (APACI)

More information

Cristina Cassetti, Ph.D.

Cristina Cassetti, Ph.D. NIAID Extramural Research Update: Recombinant Influenza Viruses and Biosafety Cristina Cassetti, Ph.D. Influenza Program Officer Division of Microbiology and Infectious Diseases NIAID Influenza virus DMID

More information

Modeling the Antigenic Evolution of Influenza Viruses from Sequences

Modeling the Antigenic Evolution of Influenza Viruses from Sequences Modeling the Antigenic Evolution of Influenza Viruses from Sequences Taijiao Jiang Center of Systems Medicine, Chinese Academy of Medical Sciences Suzhou Institute of Systems Medicine October 8-10, 2015.

More information

Enhancing Public Health Disease Surveillance, Detection, Diagnosis and Containment Capability in Nigeria.

Enhancing Public Health Disease Surveillance, Detection, Diagnosis and Containment Capability in Nigeria. Enhancing Public Health Disease Surveillance, Detection, Diagnosis and Containment Capability in Nigeria. A paper presented to the Meeting of Experts of States Parties to the Biological Weapons Convention,

More information

Personalized medecine Biomarker

Personalized medecine Biomarker Patient Disease Diagnosis Risk prediction Personalized medecine Biomarker Targeted therapies Diagnostic Theranostic: Efficay Toxicity Treatment 1 THE CASE FOR PERSONALIZED MEDICINE IS COMPELLING.. Toxicity

More information

Set the stage: Genomics technology. Jos Kleinjans Dept of Toxicogenomics Maastricht University, the Netherlands

Set the stage: Genomics technology. Jos Kleinjans Dept of Toxicogenomics Maastricht University, the Netherlands Set the stage: Genomics technology Jos Kleinjans Dept of Toxicogenomics Maastricht University, the Netherlands Amendment to the latest consolidated version of the REACH legislation REACH Regulation 1907/2006:

More information

The EUA Process at CDC Michael W. Shaw, PhD

The EUA Process at CDC Michael W. Shaw, PhD The EUA Process at CDC Michael W. Shaw, PhD Office of Infectious Diseases DECLARATION OF EMERGENCY OR THREAT JUSTIFYING EMERGENCY USE Before FDA may issue an EUA, the HHS Secretary must declare that circumstances

More information

Advanced Lecture on One Health

Advanced Lecture on One Health The 6th International Symposium Advanced Lecture on One Health 13:30~16:30 Sept 2, 2013 Lecture Hall, Graduate School of Veterinary Medicine, Hokkaido University, JAPAN Program 13:30~14:30 Dr. Ruben Donis

More information

Improving data for cervical cancer programming

Improving data for cervical cancer programming Improving data for cervical cancer programming Tools for supporting improved decision making Leanne Riley, WHO 102M Track 4 Rational The need A global absence of standardized tools and guidance, technical

More information

Influenza. Influenza vaccines (WHO position paper) Weekly Epid. Record (2005, 80: ) 287

Influenza. Influenza vaccines (WHO position paper) Weekly Epid. Record (2005, 80: ) 287 Program Management 82_19 SAGE encouraged all countries to consider their preparedness for a potential influenza pandemic, recognizing that it would occur before strain-specific vaccine can be made in significant

More information

CE Unit. Viruses and Vaccines

CE Unit. Viruses and Vaccines CE Unit Viruses and Vaccines DO NOT WRITE What is a virus? Have you ever had a virus? What is a vaccine? How is a virus different from bacteria? What are the deadliest viruses? 10. Dengue fever 50 million

More information

The 100,000 Genomes Project

The 100,000 Genomes Project The 100,000 Genomes Project Dr Matina Prapa, Scientific co ordinator Genomics England Clinical Interpretation Partnership William Harvey Research Institute Queen Mary University of London Genomics England

More information

Human H5N1 and Pandemic Vaccines Practicalities of Production: A perspective from Industry

Human H5N1 and Pandemic Vaccines Practicalities of Production: A perspective from Industry Human H5N1 and Pandemic Vaccines Practicalities of Production: A perspective from Industry Luc Hessel M.D. Pandemic Influenza Working Group European Vaccine Manufacturers 4th Joint EC/ECDC/WHO Workshop

More information

Combinatorial Vaccines for AIDS and other Infectious Diseases

Combinatorial Vaccines for AIDS and other Infectious Diseases Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Department of Health and Human Services Combinatorial Vaccines for AIDS

More information